Haplotype structures and functional polymorphic variants of the drug target enzyme aromatase (CYP19A1) in South Indian population
- 28 July 2013
- journal article
- Published by Springer Nature in Medical Oncology
- Vol. 30 (3) , 1-10
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Potential Role of Aromatase over Estrogen Receptor Gene Polymorphisms in Migraine Susceptibility: A Case Control Study from North IndiaPLOS ONE, 2012
- Effect of CYP19 rs6493497 and rs7176005 haplotype status on in vivo aromatase transcription, plasma and tissue estrogen levels in postmenopausal womenThe Journal of Steroid Biochemistry and Molecular Biology, 2012
- Genetic polymorphisms of drug‐metabolizing phase I enzymes CYP2E1, CYP2A6 and CYP3A5 in South Indian populationFundamental & Clinical Pharmacology, 2011
- Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivorsBreast Cancer Research, 2011
- Genetic analysis of OCT1 gene polymorphisms in an Indian populationIndian Journal of Human Genetics, 2011
- A polymorphism at the 3'-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozoleBMC Cancer, 2010
- Association between CYP19 polymorphisms and breast cancer risk: results from 10,592 cases and 11,720 controlsBreast Cancer Research and Treatment, 2010
- Functional Genetic Polymorphisms in the Aromatase GeneCYP19Vary the Response of Breast Cancer Patients to Neoadjuvant Therapy with Aromatase InhibitorsCancer Research, 2010
- Reconstructing Indian population historyNature, 2009
- Association of two common single-nucleotide polymorphisms in the CYP19A1 locus and ovarian cancer riskEndocrine-Related Cancer, 2008